The Feedback Loop Between MiR-21, PDCD4 and AP-1 Functions As a Driving Force for Renal Fibrogenesis
Overview
Authors
Affiliations
Renal fibrosis is a final common pathway of chronic kidney disease. Sustained activation of fibroblasts is considered to play a key role in perpetuating renal fibrosis but the driving force in the perpetuation stage is only partially understood. To date, some investigations have specifically identified overexpression of microRNA 21 (miR-21) in the progression of kidney fibrosis. Nevertheless, the precise role of miR-21 in fibroblast activation remains largely unknown. In this study, we found that miR-21 was significantly upregulated in activated fibroblasts and that it maintained itself at constant high levels by employing an auto-regulatory loop between miR-21, PDCD4 and AP-1. Persistently upregulated miR-21 suppressed protein expression of Smad7 and, eventually, enhanced the TGF-β1/Smad pathway to promote fibroblast activation. More importantly, we found miR-21 sequestration with miR-21 antagomir or AP-1 inhibitors attenuated unilateral ureteral obstruction (UUO)-induced renal fibrosis. miR-21-knockout mice also suffered far less interstitial fibrosis in response to kidney injury. Altogether, these data suggest that miR-21 is a main driving force of fibroblast activation and keeps its high expression level by employing a double negative autoregulatory loop. Targeting this aberrantly activated feedback loop may provide new therapeutic strategy in treating fibrotic kidneys.
Xiang Y, Huang G, Luo C, Jiang J, Zhang T, Zeng Q J Inflamm Res. 2024; 17:11605-11629.
PMID: 39737099 PMC: 11682943. DOI: 10.2147/JIR.S490457.
How PPAR-alpha mediated inflammation may affect the pathophysiology of chronic kidney disease.
Masenga S, Desta S, Hatcher M, Kirabo A, Lee D Curr Res Physiol. 2024; 8:100133.
PMID: 39665027 PMC: 11629568. DOI: 10.1016/j.crphys.2024.100133.
MiR-21 attenuates FAS-mediated cardiomyocyte apoptosis by regulating HIPK3 expression.
Wang X, Zhang T, Zhai J, Wang Z, Wang Y, He L Biosci Rep. 2023; 43(9).
PMID: 37581369 PMC: 10500225. DOI: 10.1042/BSR20230014.
Maddali P, Ambesi A, McKeown-Longo P PLoS One. 2023; 18(5):e0286390.
PMID: 37228128 PMC: 10212165. DOI: 10.1371/journal.pone.0286390.
MicroRNA in the Diagnosis and Treatment of Doxorubicin-Induced Cardiotoxicity.
Kuang Z, Wu J, Tan Y, Zhu G, Li J, Wu M Biomolecules. 2023; 13(3).
PMID: 36979503 PMC: 10046787. DOI: 10.3390/biom13030568.